Colorectal cancer risk and dyslipidemia: A case-cohort study nested in an Italian multicentre cohort

Cancer Epidemiology

Volumn 38, Issue 2, 2014, Pages 144-151

  Agnoli, Claudia ^a   Grioni, Sara ^a   Sieri, Sabina ^a   Sacerdote, Carlotta ^b,c   Vineis, Paolo ^c,d   Tumino, Rosario ^e   Giurdanella, Maria Concetta ^e   Pala, Valeria ^a   Mattiello, Amalia ^f   Chiodini, Paolo ^g   Iacoviello, Licia ^h   De Curtis, Amalia ^h   Cattaneo, Leonardo ^a   van Duijnhoven, Fränzel J B ^i,j   Panico, Salvatore ^f   Krogh, Vittorio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Center for Cancer Prevention CPO Piemonte   (Italy)

^c Human Genetics Foundation   (Italy)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e ASP 7   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g SECOND UNIVERSITY OF NAPLES   (Italy)

^h CATHOLIC UNIVERSITY   (Italy)

ⁱ NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^j WAGENINGEN UNIVERSITY   (Netherlands)

more..

Author keywords

Cholesterol; Colorectal cancer; Prospective study; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ASCENDING COLON; CANCER GROWTH; CANCER RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DESCENDING COLON; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM CANCER; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COLORECTAL NEOPLASMS; DYSLIPIDEMIAS; EPIDEMIOLOGY; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

CASE-CONTROL STUDIES; COHORT STUDIES; COLORECTAL NEOPLASMS; DYSLIPIDEMIAS; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84898025449     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2014.02.002     Document Type: Article

References (49)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). J Am Med Assoc 2001, 285(19):2486-2497.
2. Borena W., Stocks T., Jonsson H., Strohmaier S., Nagel G., Bjorge T., et al. Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. Cancer Causes Control 2011, 22(2):291-299.
3. Cust A.E., Kaaks R., Friedenreich C., Bonnet F., Laville M., Tjonneland A., et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2007, 14(3):755-767.
4. Swanson C.A., Potischman N., Barrett R.J., Berman M.L., Mortel R., Twiggs L.B., et al. Endometrial cancer risk in relation to serum lipids and lipoprotein levels. Cancer Epidemiol Biomarkers Prev 1994, 3(7):575-581.
5. Tulinius H., Sigfusson N., Sigvaldason H., Bjarnadottir K., Tryggvadottir L. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 1997, 6(11):863-873.
6. Ulmer H., Borena W., Rapp K., Klenk J., Strasak A., Diem G., et al. Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. Br J Cancer 2009, 101(7):1202-1206.
7. Hoyer A.P., Engholm G. Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women. Cancer Causes Control 1992, 3(5):403-408.
8. Melvin J.C., Seth D., Holmberg L., Garmo H., Hammar N., Jungner I., et al. Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study. Cancer Epidemiol Biomarkers Prev 2012, 21(8):1381-1384.
9. Kok D.E., van Roermund J.G., Aben K.K., den Heijer M., Swinkels D.W., Kampman E., et al. Blood lipid levels and prostate cancer risk; a cohort study. Prostate Cancer Prostatic Dis 2011, 14(4):340-345.
10. Rose G., Blackburn H., Keys A., Taylor H.L., Kannel W.B., Paul O., et al. Colon cancer and blood-cholesterol. Lancet 1974, 1(7850):181-183.
11. Sidney S., Farquhar J.W. Cholesterol, cancer, and public health policy. Am J Med 1983, 75(3):494-508.
12. Williams R.R., Sorlie P.D., Feinleib M., McNamara P.M., Kannel W.B., Dawber T.R. Cancer incidence by levels of cholesterol. J Am Med Assoc 1981, 245(3):247-252.
13. Kagan A., McGee D.L., Yano K., Rhoads G.G., Nomura A. Serum cholesterol and mortality in a Japanese-American population: the Honolulu Heart program. Am J Epidemiol 1981, 114(1):11-20.
14. Law M.R., Thompson S.G. Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies. Cancer Causes Control 1991, 2(4):253-261.
15. Aleksandrova K., Boeing H., Jenab M., Bas Bueno-de-Mesquita H., Jansen E., van Duijnhoven F.J., et al. Metabolic syndrome and risks of colon and rectal cancer: the European prospective investigation into cancer and nutrition study. Cancer Prev Res (Phila) 2011, 4(11):1873-1883.
16. Stocks T., Lukanova A., Bjorge T., Ulmer H., Manjer J., Almquist M., et al. Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can). Cancer 2011, 117(11):2398-2407.
17. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23(5):469-480.
18. Pais R., Silaghi H., Silaghi A.C., Rusu M.L., Dumitrascu D.L. Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol 2009, 15(41):5141-5148.
19. Esteve E., Ricart W., Fernandez-Real J.M. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 2005, 24(1):16-31.
20. Hutcheson R., Rocic P. The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration. Exp Diabetes Res 2012, 2012:271028.
21. Avramoglu R.K., Basciano H., Adeli K. Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta 2006, 368(1-2):1-19.
22. Chung Y.W., Han D.S., Park Y.K., Son B.K., Paik C.H., Lee H.L., et al. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig Liver Dis 2006, 38(9):668-672.
23. Tsushima M., Nomura A.M., Lee J., Stemmermann G.N. Prospective study of the association of serum triglyceride and glucose with colorectal cancer. Dig Dis Sci 2005, 50(3):499-505.
24. van Duijnhoven F.J., Bueno-de-Mesquita H.B., Calligaro M., Jenab M., Pischon T., Jansen E.H., et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut 2011, 60(8):1094-1102.
25. Palli D., Berrino F., Vineis P., Tumino R., Panico S., Masala G., et al. A molecular epidemiology project on diet and cancer: the EPIC-Italy Prospective Study. Design and baseline characteristics of participants. Tumori 2003, 89(6):586-593.
26. Pala V., Sieri S., Palli D., Salvini S., Berrino F., Bellegotti M., et al. Diet in the Italian EPIC cohorts: presentation of data and methodological issues. Tumori 2003, 89(6):594-607.
27. Rose G. Standardisation of observers in blood pressure measurement. Lancet 1965, 1(7387):673-674.
28. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502.
29. Prentice R.L. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986, 73(1):1-11.
30. Schatzkin A., Hoover R.N., Taylor P.R., Ziegler R.G., Carter C.L., Albanes D., et al. Site-specific analysis of total serum cholesterol and incident cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Cancer Res 1988, 48(2):452-458.
31. Tornberg S.A., Holm L.E., Carstensen J.M., Eklund G.A. Risks of cancer of the colon and rectum in relation to serum cholesterol and beta-lipoprotein. N Engl J Med 1986, 315(26):1629-1633.
32. Ashbeck E.L., Jacobs E.T., Martinez M.E., Gerner E.W., Lance P., Thompson P.A. Components of metabolic syndrome and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 2009, 18(4):1134-1143.
33. Saydah S.H., Platz E.A., Rifai N., Pollak M.N., Brancati F.L., Helzlsouer K.J. Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2003, 12(5):412-418.
34. Strohmaier S., Edlinger M., Manjer J., Stocks T., Bjorge T., Borena W., et al. Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can). PLoS One 2013, 8(1):e54242.
35. Sterne J.A., Gavaghan D., Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000, 53(11):1119-1129.
36. Glebov O.K., Rodriguez L.M., Nakahara K., Jenkins J., Cliatt J., Humbyrd C.J., et al. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 2003, 12(8):755-762.
37. Hill M.J., Drasar B.S., Hawksworth G., Aries V., Crowther J.S., Williams R.E. Bacteria and aetiology of cancer of large bowel. Lancet 1971, 1(7690):95-100.
38. Kishida T., Taguchi F., Feng L., Tatsuguchi A., Sato J., Fujimori S., et al. Analysis of bile acids in colon residual liquid or fecal material in patients with colorectal neoplasia and control subjects. J Gastroenterol 1997, 32(3):306-311.
39. McMichael A.J., Potter J.D. Host factors in carcinogenesis: certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer. J Natl Cancer Inst 1985, 75(2):185-191.
40. Debruyne P.R., Bruyneel E.A., Li X., Zimber A., Gespach C., Mareel M.M. The role of bile acids in carcinogenesis. Mutat Res 2001, 480(48135):9-369.
41. Erdman S.E., Poutahidis T. Roles for inflammation and regulatory T cells in colon cancer. Toxicol Pathol 2010, 38(1):76-87.
42. Kim S., Keku T.O., Martin C., Galanko J., Woosley J.T., Schroeder J.C., et al. Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res 2008, 68(1):323-328.
43. Wertheim B.C., Smith J.W., Fang C., Alberts D.S., Lance P., Thompson P.A. Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis. Cancer Prev Res (Phila) 2012, 5(2):197-204.
44. da Silva P.R., Tatsch E., Bochi G.V., Kober H., Duarte T., Dos Santos Montagner G.F., et al. Assessment of oxidative, inflammatory, and fibrinolytic biomarkers and DNA strand breakage in hypercholesterolemia. Inflammation 2013, 36(4):869-877.
45. Valko M., Izakovic M., Mazur M., Rhodes C.J., Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004, 266(1-2):37-56.
46. Esposito K., Chiodini P., Colao A., Lenzi A., Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 2012, 35(11):2402-2411.
47. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001, 131(11 Suppl.):3109S-3120S.
48. Shumak S.L., Campbell N.R. Intraindividual variation in lipid and lipoprotein levels. CMAJ 1993, 149(6):843-844.
49. Shih W.J., Bachorik P.S., Haga J.A., Myers G.L., Stein E.A. Estimating the long-term effects of storage at -70°C on cholesterol, triglyceride, and HDL-cholesterol measurements in stored sera. Clin Chem 2000, 46(3):351-364.